IIOT-OXYS Inc (ITOX): If they can update us on the nature of t...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: Lottalead post# 5994

Monday, 09/13/2021 11:45:13 PM

Monday, September 13, 2021 11:45:13 PM

If they can update us on the nature of the pharmaceutical company relationship, or what’s in the pipeline; that would be great

Keep Last Read

Next 10 Prev Next

Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 06:32:02 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/16/2024 05:07:53 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/24/2024 03:24:34 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/01/2023 09:01:13 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 08:26:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/07/2023 08:30:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2023 09:29:11 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/25/2023 12:30:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2023 03:56:43 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 09:25:36 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 04:17:19 PM
Form 8-K - Current report • Edgar (US Regulatory) • 07/31/2023 08:01:12 PM

InvestorsHub NewsWire

Only $200 per official company press release!